Integrated analysis of two phase 2 trials of nivolumab in metastatic rare solid cancer with dMMR or pMMR (MASTER KEY sub-studies: ROCK and ROLL trial). This is an ASCO Meeting Abstract from the 2024 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results